PNC Financial Services Group
YMAB

PNC Financial Services Group’s Y-mAbs Therapeutics YMAB Stock Holding History

PNC Financial Services Group’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-129
Closed -$582 – 5245
2025
Q2 		$582 Buy
+129
New +$580 ﹤0.01% 4659

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PNC Financial Services Group's YMAB Position: Q3 2025 in Review

PNC Financial Services Group sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 129 shares — an estimated $582 sold.

PNC Financial Services Group first reported a position in YMAB in Q2 2025 and held it in 1 quarter. The position peaked at $582 in Q2 2025. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • PNC Financial Services Group reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 129 Y-mAbs Therapeutics shares in Q3 2025, an estimated $582.
  • PNC Financial Services Group first reported a position in Y-mAbs Therapeutics in Q2 2025 and held it in 1 quarter.
  • PNC Financial Services Group's Y-mAbs Therapeutics position peaked at $582 in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.